August 7, 2018 / 6:17 PM / a month ago

BUZZ-Bausch Health Cos: U.S.-listed shares rise after profit beat

** Drug maker’s U.S.-listed shares up 5.5 pct at $23.77

** Q2 profit beats estimates after revenue generated by its Salix unit rose year-over-year

** Bausch raises 2018 adj EBITDA forecast to $3.20 bln-$3.35 bln

** BHC underlined its commitment to reduce its debt, completing six refinancing transactions in the quarter

** EPS has beaten analysts’ estimates for the fifth straight quarter

** Up to Monday’s close, stock had risen nearly 50 pct in the last 12 months (Reporting by Ashwin Shyam in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below